Evidence map›Paper›PMID 39961948›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Regional distribution of carbapenemase-producing Acinetobacter baumannii isolates in southern Spain (Andalusia).

Felipe Fernández-Cuenca, Salud Rodríguez-Pallares, Lorena López-Cerero, José Gutiérrez-Fernández, María Fe Bautista, Juan Antonio Sánchez Gómez, Waldo Sánchez-Yebra Romera, Mercedes Delgado, Esther Recacha, Alvaro Pascual

Abstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. High-Resolution Genomic Surveillance of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Determinants of Antimicrobial Resistance inInternational journal of microbiology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Felipe Fernández-CuencaUniversity Hospital Virgen Macarena, Seville, Spain.
Salud Rodríguez-PallaresServicio de Microbiología e Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Lorena López-CereroUniversity Hospital Virgen Macarena, Seville, Spain. llopez@us.es.
José Gutiérrez-FernándezUniversity Hospital Virgen de Las Nieves, Granada, Spain.
María Fe BautistaLa-Inmaculada Hospital, Almería, Spain.
Juan Antonio Sánchez GómezUGC Biotechnology, Unit of Microbiology, University Hospital Torrecárdenas, Almería, Spain.
Waldo Sánchez-Yebra RomeraUGC Biotechnology, Unit of Microbiology, University Hospital Torrecárdenas, Almería, Spain.
Mercedes DelgadoUniversity Hospital Virgen Macarena, Seville, Spain.
Esther RecachaUniversity Hospital Virgen Macarena, Seville, Spain.
Alvaro PascualUniversity Hospital Virgen Macarena, Seville, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is the first study conducted in southern Spain to determine i) the population structure (PS) of carbapenem-resistant (CR) Acinetobacter baumannii isolates by multilocus sequencing typing (MLST) and core genome MLST (cgMLST) and ii) the association between the sequence type ST and the bla

methodsOf 336 isolates submitted to the Andalusian reference laboratory (PIRASOA; December 2017-2020), 73 were subjected to WGS (MiSeq). The following analyses were performed: bacterial identification (ribosomal MLST), carbapenemase gene detection (Resfinder 4.0), PS delineation (MLST by MLSTfinder 2.0 and cgMLST by Ridom SeqSphere

resultsThe carbapenemases detected were bla

conclusionsThe PS of CR A. baumannii in Andalusia is characterized by a dominant ST2/bla

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacterial Proteinsbeta-LactamasesAnti-Bacterial AgentsCarbapenemsHumansMicrobial Sensitivity TestsMultilocus Sequence TypingSpainAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAcinetobacter baumanniiInterregional spreadKL typeSouthern of Spain

Identifiers

PMID39961948
PMCPMC12062160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.